activistcompany
Chain of Lakes reaches agreement with Lantronix (LTRX)
Key Summary: On June 2, 2025, Chain of Lakes Investment Fund said the shares are deeply undervalued, citing a 95%
activistcompany
Profile of companies that are targetted by activists
activistcompany
Galloway Capital Partners Urges Babcock & Wilcox Enterprises (BW) to Unlock Value, Citing Growth and Strategic Opportunity
Key Summary: On June 2, 2025, Galloway Capital Partners (4.31%) urged B&W to unlock shareholder value, citing
activistcompany
Gary S. Rosenbach reaches agreement with Harte Hanks (HHS)
Key Summary: On May 14, 2025, Rosenbach entered into a cooperation agreement with the company, agreeing to standstill provisions
M.
activistcompany
American Public Education appoints Michael D. Braner of 325 Capital LLC to its board
Key Summary: On March 20, 2023, 325 Capital entered into a Cooperation Agreement with the company and pursuant to it,
activistcompany
Weiss Asset Management secured a board seat in Theravance Biopharma, Inc
Key Summary: On April 12, 2023, James C. Kelly, a managing director of Weiss Asset Management, was appointed to the
activistcompany
H Partners entered into a Cooperation Agreement with Six Flags Entertainment Corporation
Key Summary: On December 21, 2022, Land & Buildings Investment Management (3%) issued a presentation detailing why it believes the
activistcompany
Dollar Tree (DLTR) settled with Mantle Ridge; Adds Dreiling to board
Key Summary: On March 8, 2022, the company reached a settlement with Mantle Ridge and pursuant to it, the company
activistcompany
Van Herk Investments sent a letter to the Board of ProQR Therapeutics (PRQR)
Key Summary: On May 23, 2025, Van Herk Investments B.V., holding over 10% of ProQR, opposes the reappointments of
activistcompany
Gary Gelbfish, M.D. Appointed as Observer to the CorMedix’ Board of Directors by Elliott Management
Key Summary: On June 27, 2017, Elliott Associates announced that Dr. Gary Gelbfish has been appointed as a Board Observer
activistcompany
Galloway Urges Strategic Review to Address Undervaluation at Global Crossing Airlines Group (JETBF)
Key Summary: Galloway Capital Partners (4.33%) sent a letter urging the company to explore strategic options—including a sale,
activistcompany
Garden Investment Management entered into a Cooperation Agreement with Middleby Corp (MIDD)
Key Summary: On February 24, 2025, Garden Investment Management entered into a Cooperation Agreement with the company. Pursuant to the
activistcompany
JBS S.A. Shareholders Approve Dual Listing on NYSE and B3
Key Summary: On May 15, 2025, Mason Capital Management (2.4%) urged SEC to investigate ISS and Glass Lewis over
activistcompany
Theofilos and MAZ Partners plan to seek Board, Management changes at electroCore, Inc (ECOR)
Key Summary: On May 14, 2025, Charles S. Theofilos (6%) and MAZ Partners (1.8%) said they are evaluating changes
activistcompany
Wynnefield Partners entered into a cooperation agreement with Quest Resource Holding Corp (QRHC)
Key Summary: On May 7, 2025, the company entered into a cooperation agreement with Wynnefield Partners
Market Cap: $51 million|
activistcompany
BML Capital Urges AN2 Therapeutics, Inc. (ANTX) to Liquidate After Drug Failure
Key Summary: On May 7, 2025, BML Capital (19.1%) urged AN2’s Board to sell or liquidate the company
activistcompany
13D weekly report - Apr 28, 2025 to May 02, 2025
Table of content
Trium Capital Rejects Acelyrin (SLRN)-Alumis Merger, Urges Liquidation Instead
Key Summary: On April 29, 2025, Trium
activistcompany
Starboard Highlights Salesforce's (CRM)Operational Gains and Future Potential
Key Summary: On October 20, 2024, Starboard highlighted Salesforce Inc.'s significant improvements in operating margins and profitability in
activistcompany
Trium Capital Rejects Acelyrin (SLRN)-Alumis Merger, Urges Liquidation Instead
Key Summary: On April 29, 2025, Trium Capital opposes the Acelyrin-Alumis merger, citing undervaluation, flawed process, ignored alternatives, and conflicts